Dr. Elizabeth Brunk was awarded the 2025 PhRMA Foundation Faculty Starter Grant in Drug Discovery! Dr. Brunk leads a systems genomics lab that integrates single-cell technologies and artificial intelligence to study how cancer cells rapidly adapt their DNA. Her groundbreaking research focuses on identifying and targeting these genetic adaptations to enhance patient treatment responses and develop more durable cancer therapies. This prestigious grant will support her efforts in advancing precision medicine and drug discovery, paving the way for innovative approaches to combat cancer.
Click 聽to read more
Adding to her many accomplishments, Dr. Brunk was selected by NSF to lead an NCEMS Working Group. This group focuses on advancing computational models, data integration, and predictive analytics to better understand microbial ecosystems and their impact on health. These interdisciplinary groups bring together experts to tackle pressing challenges in environmental microbiome science. Read more about the initiative here: !